Tag Archives: infliximab

10Dec/13
Takeda’s Inflammatory Bowel Medicine Wins EU Regulatory Backing

FDA Committee Recommends Approval of Vedolizumab

FDA Committee Recommends Approval of Takeda’s Investigational Biologic Vedolizumab, DEERFIELD, Ill. and OSAKA, Japan, Dec. 9, 2013 weneedideas.ca Takeda Pharmaceutical Company Limited (“Takeda”) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., todayRead More…